↓ Skip to main content

Dove Medical Press

Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations

Overview of attention for article published in OncoTargets and therapy, January 2022
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • Good Attention Score compared to outputs of the same age (75th percentile)
  • High Attention Score compared to outputs of the same age and source (96th percentile)

Mentioned by

news
1 news outlet
twitter
1 X user

Citations

dimensions_citation
10 Dimensions

Readers on

mendeley
12 Mendeley
Title
Pexidartinib in the Management of Advanced Tenosynovial Giant Cell Tumor: Focus on Patient Selection and Special Considerations
Published in
OncoTargets and therapy, January 2022
DOI 10.2147/ott.s345878
Pubmed ID
Authors

Anna Vaynrub, John H Healey, William Tap, Max Vaynrub

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 12 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 12 100%

Demographic breakdown

Readers by professional status Count As %
Other 2 17%
Student > Doctoral Student 1 8%
Student > Bachelor 1 8%
Student > Master 1 8%
Researcher 1 8%
Other 0 0%
Unknown 6 50%
Readers by discipline Count As %
Pharmacology, Toxicology and Pharmaceutical Science 3 25%
Medicine and Dentistry 2 17%
Nursing and Health Professions 1 8%
Unknown 6 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 7. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 01 June 2022.
All research outputs
#5,464,577
of 26,178,577 outputs
Outputs from OncoTargets and therapy
#268
of 3,021 outputs
Outputs of similar age
#128,690
of 529,515 outputs
Outputs of similar age from OncoTargets and therapy
#1
of 26 outputs
Altmetric has tracked 26,178,577 research outputs across all sources so far. Compared to these this one has done well and is in the 78th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,021 research outputs from this source. They receive a mean Attention Score of 3.0. This one has done particularly well, scoring higher than 90% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 529,515 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 75% of its contemporaries.
We're also able to compare this research output to 26 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 96% of its contemporaries.